OS Support (DSWR) 10-Q 20 Jul 21 2021 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Mar. 31, 2021	Jul. 07, 2021
Cover [Abstract]
Entity Registrant Name	OS Support, Inc.
Entity Central Index Key	0001658520
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	No
Document Period End Date	Mar. 31, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Entity Ex Transition Period	true
Entity Common Stock Shares Outstanding		7,093,750
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	No

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2021	Jun. 30, 2020
ASSETS
TOTAL ASSETS	$ 0	$ 0
CURRENT LIABILITIES
Accounts payable and accrued liabilities	29,269	38,052
Loan from related party	43,817	13,430
TOTAL CURRENT LIABILITIES	73,086	51,482
STOCKHOLDERS' EQUITY (DEFICIT)
Common Stock Authorized 75,000,000 shares of common stock, $0.001 par value, Issued and outstanding 7,093,750 shares of Common Stock at March31, 2021 and June 2020 respectively	7,094	7,094
Additional Paid in Capital	3,656	3,656
Accumulated Deficit	(83,836)	(62,232)
TOTAL STOCKHOLDERS' EQUITY/(DEFICIT)	(73,086)	(51,482)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY/(DEFICIT)	$ 0	$ 0

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2021	Jun. 30, 2020
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	7,093,750	7,093,750
Common stock, shares outstanding	7,093,750	7,093,750

CONDENSED STATEMENT OF OPERATIO

CONDENSED STATEMENT OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
CONDENSED STATEMENT OF OPERATIONS (Unaudited)
REVENUE	$ 0	$ 0	$ 0	$ 0
EXPENSES
General and Administrative	669	159	12,311	159
Professional Fees	4,750	2,250	9,250	6,750
TOTAL OPERATING EXPENSES	5,419	2,409	21,561	6,909
OTHER INCOME (EXPENSES)
Exchange Gain (Loss)	0	(31)	(121)	(537)
Interest Income	27	33	78	103
NET LOSS	$ (5,392)	$ (2,407)	$ (21,604)	$ (7,343)
BASIC AND DILUTED LOSS PER COMMON SHARE
Earning per share	$ 0	$ 0	$ 0	$ 0
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	7,093,750	7,093,750	7,093,750	7,093,750

CONDENSED STATEMENTS OF STOCKHO

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)	Total	Common Stock	Share Subscriptions Receivable	Additional Paid-In Capital	Accumulated Deficit
Balance, shares at Jun. 30, 2019		7,093,750
Balance, amount at Jun. 30, 2019	$ (38,941)	$ 7,094	$ 0	$ 3,656	$ (49,691)
Net Loss	(2,701)		0	0	(2,701)
Balance, shares at Sep. 30, 2019		7,003,750
Balance, amount at Sep. 30, 2019	(41,642)	$ 7,094	0	3,656	(53,392)
Balance, shares at Jun. 30, 2019		7,093,750
Balance, amount at Jun. 30, 2019	(38,941)	$ 7,094	0	3,656	(49,691)
Net Loss	(7,343)
Balance, shares at Mar. 31, 2020		7,003,750
Balance, amount at Mar. 31, 2020	(70,101)	$ 7,094	0	3,656	(80,851)
Balance, shares at Sep. 30, 2019		7,003,750
Balance, amount at Sep. 30, 2019	(41,642)	$ 7,094	0	3,656	(53,392)
Net Loss	(2,235)				(2,235)
Balance, shares at Dec. 31, 2019		7,003,750
Balance, amount at Dec. 31, 2019	(43,877)	$ 7,094	0	3,656	(54,627)
Net Loss	(2,407)				(2,407)
Balance, shares at Mar. 31, 2020		7,003,750
Balance, amount at Mar. 31, 2020	(70,101)	$ 7,094	0	3,656	(80,851)
Balance, shares at Jun. 30, 2020		7,093,750
Balance, amount at Jun. 30, 2020	(51,482)	$ 7,094	0	3,656	(62,232)
Net Loss	(2,311)		0	0	(2,311)
Balance, shares at Sep. 30, 2020		7,003,750
Balance, amount at Sep. 30, 2020	(53,793)	$ 7,094	0	3,656	(64,543)
Balance, shares at Jun. 30, 2020		7,093,750
Balance, amount at Jun. 30, 2020	(51,482)	$ 7,094	0	3,656	(62,232)
Net Loss	(21,604)
Balance, shares at Mar. 31, 2021		7,003,750
Balance, amount at Mar. 31, 2021	(73,086)	$ 7,094	0	3,656	(83,836)
Balance, shares at Sep. 30, 2020		7,003,750
Balance, amount at Sep. 30, 2020	(53,793)	$ 7,094	0	3,656	(64,543)
Net Loss	(13,901)				(13,901)
Balance, shares at Dec. 31, 2020		7,003,750
Balance, amount at Dec. 31, 2020	(67,694)	$ 7,094	0	3,656	(78,444)
Net Loss	(5,392)				(5,392)
Balance, shares at Mar. 31, 2021		7,003,750
Balance, amount at Mar. 31, 2021	$ (73,086)	$ 7,094	$ 0	$ 3,656	$ (83,836)

CONDENSED STATEMENT OF CASH FLO

CONDENSED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended				9 Months Ended
	Mar. 31, 2021	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Mar. 31, 2021	Mar. 31, 2020
OPERATING ACTIVITIES
Net loss	$ (5,392)	$ (2,311)	$ (2,407)	$ (2,701)	$ (21,604)	$ (7,343)
Adjustment to reconcile net loss to net cash used in operating activities:
Increase (decrease) in Payables					(8,783)	6,750
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES					(30,387)	(593)
FINANCING ACTIVITIES
Loan from related party					30,387	593
NET CASH PROVIDED BY FINANCING ACTIVITIES					30,387	593
NET INCREASE (DECREASE) IN CASH					0	0
CASH, BEGINNING OF PERIOD		$ 0		$ 0	0	0
CASH, END OF PERIOD	$ 0		$ 0		0	0
Cash paid for:
Interest					0	0
Income taxes					$ 0	$ 0

NATURE OF OPERATIONS AND BASIS

NATURE OF OPERATIONS AND BASIS OF PRESENTATION	9 Months Ended
	Mar. 31, 2021
NATURE OF OPERATIONS AND BASIS OF PRESENTATION
NOTE 1 - NATURE OF OPERATIONS AND BASIS OF PRESENTATION	The Company was incorporated in the State of Nevada as a for-profit Company on April 15, 2015 and established a fiscal year end of June 30. The Company is organized to initially provide a pay as you go support service for the top 10 free open sources software programs. Going Concern To date the Company has generated no revenues from its business operations and has incurred operating losses since inception of $83,836. As at March 31, 2021, the Company has a working capital deficit of $73,086. The Company requires additional funding to meet its ongoing obligations and to fund anticipated operating losses. The ability of the Company to continue as a going concern is dependent on raising capital to fund its initial business plan and ultimately to attain profitable operations. Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern. The Company intends to continue to fund its business by way of private placements and advances from related parties as may be required. As of March 31, 2021, the Company has issued 7,093,750 founders shares at $0.001 per share for net proceeds of $7,000 to the Company, and 93,750 shares in private placements at $0.04 per share for net proceeds of $3,750. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Mar. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended June 30, 2020, included in the Company’s Annual Report on Form 10-K filed with the SEC on July 31, 2020. In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position as of March 31, 2021, and results of operations for the three and the nine month periods ended March 31, 2021 and 2020. Use of Estimates and Assumptions Preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Accordingly, actual results could differ from those estimates. Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. Foreign currency and Translation The Company translates the foreign currency financial statements into US Dollars using the year or reporting period end of average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830-10, Foreign Currency Matters (“ASC 830-10”). Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity (deficit). Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the results of operations. Fair Value of Financial Instruments The carrying amount of the Company’s financial assets and liabilities approximates their fair values due to their short term maturities. Loss per Common Share The basic earnings (loss) per share is calculated by dividing the Company’s net income available to common shareholders by the weighted average number of common shares during the year. The diluted earnings (loss) per share is calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company. As of March 31, 2021, there were 7,093,750 shares of common stock outstanding. Income Taxes The Company follows the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax balances and tax loss carry-forwards. Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates expected to apply to the taxable income in the years in which those differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment or substantive enactment. Stock-based Compensation The Company follows ASC 718-10, “Stock Compensation”, which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 is a revision to SFAS No. 123, “Accounting for Stock-Based Compensation,” and supersedes Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees,” and its related implementation guidance. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized. The Company has not adopted a stock option plan and has not granted any stock options. As of March 31, 2021, the Company had not adopted a stock option plan nor had it granted any stock options. Accordingly no stock-based compensation has been recorded to date. Recent Accounting Pronouncements The Company does not expect the adoption of any recent accounting pronouncements to have a material impact on its financial statements.

COMMON STOCK

COMMON STOCK	9 Months Ended
	Mar. 31, 2021
COMMON STOCK
NOTE 3 - COMMON STOCK	The Company’s capitalization is 75,000,000 common shares with a par value of $0.001 per share. No preferred shares have been authorized or issued. On July 4, 2015 the Company issued 7,000,000 common shares at $0.001 per share to the sole director and President of the Company for cash proceeds of $7,000. In July and August 2017, the Company issued 93,750 common shares for cash at $0.04 per share for net proceeds to the Company of $3,750. As of March 31, 2021, the Company had not adopted a stock option plan nor had it granted any stock options. Accordingly no stock-based compensation has been recorded to date. As of March 31, 2021, 7,093,750 shares issued and outstanding.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Mar. 31, 2021
RELATED PARTY TRANSACTIONS
NOTE 4 - RELATED PARTY TRANSACTIONS	As of March 31, 2021, the balance of loan from Paramjit Mann, the Company’s Director is $43,817. The amounts due to the related party are unsecured and non- interest-bearing with no set terms of repayment.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Mar. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended June 30, 2020, included in the Company’s Annual Report on Form 10-K filed with the SEC on July 31, 2020. In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position as of March 31, 2021, and results of operations for the three and the nine month periods ended March 31, 2021 and 2020.
Use of Estimates and Assumptions	Preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Accordingly, actual results could differ from those estimates.
Cash and Cash Equivalents	For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.
Foreign Currency and Translation	The Company translates the foreign currency financial statements into US Dollars using the year or reporting period end of average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830-10, Foreign Currency Matters (“ASC 830-10”). Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity (deficit). Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the results of operations.
Fair Value of Financial Instruments	The carrying amount of the Company’s financial assets and liabilities approximates their fair values due to their short term maturities.
Loss per Common Share	The basic earnings (loss) per share is calculated by dividing the Company’s net income available to common shareholders by the weighted average number of common shares during the year. The diluted earnings (loss) per share is calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company. As of March 31, 2021, there were 7,093,750 shares of common stock outstanding.
Income Taxes	The Company follows the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax balances and tax loss carry-forwards. Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates expected to apply to the taxable income in the years in which those differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment or substantive enactment.
Stock-based Compensation	The Company follows ASC 718-10, “Stock Compensation”, which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 is a revision to SFAS No. 123, “Accounting for Stock-Based Compensation,” and supersedes Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees,” and its related implementation guidance. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized. The Company has not adopted a stock option plan and has not granted any stock options. As of March 31, 2021, the Company had not adopted a stock option plan nor had it granted any stock options. Accordingly no stock-based compensation has been recorded to date.
Recent Accounting Pronouncements	The Company does not expect the adoption of any recent accounting pronouncements to have a material impact on its financial statements.

NATURE OF OPERATIONS AND BASI_2

NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	9 Months Ended	72 Months Ended
	Mar. 31, 2021	Mar. 31, 2021	Aug. 31, 2017
Operating loss		$ (83,836)
Working capital deficit	$ (73,086)	$ (73,086)
Price per share			$ 0.04
Private Placement [Member]
Stock issued during period shares, shares	93,750
Stock issued during period shares, amount	$ 3,750
Price per share	$ 0.04	$ 0.04
Founder [Member]
Stock issued during period shares, shares	7,093,750
Stock issued during period shares, amount	$ 7,000
Price per share	$ 0.001	$ 0.001

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - shares	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	7,093,750	7,093,750	7,093,750	7,093,750

COMMON STOCK (Details Narrative

COMMON STOCK (Details Narrative) - USD ($)	1 Months Ended	2 Months Ended
	Jul. 04, 2015	Aug. 31, 2017	Mar. 31, 2021	Jun. 30, 2020
Common stock, par value			$ 0.001	$ 0.001
Common stock, shares authorized			75,000,000	75,000,000
Common stock, shares issued			7,093,750	7,093,750
Common stock, shares outstanding			7,093,750	7,093,750
Stock issued during period shares, shares		93,750
Stock issued during period shares, amount		$ 3,750
Price per share		$ 0.04
President and Director [Member]
Stock issued during period shares, shares	7,000,000
Stock issued during period shares, amount	$ 7,000
Price per share	$ 0.001

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Mar. 31, 2021	Jun. 30, 2020
Loan from related party	$ 43,817	$ 13,430
Paramjit Mann [Member]
Loan from related party	$ 43,817